265 related articles for article (PubMed ID: 2159367)
21. Platelet-activating factor production in stimulated macrophages is down-regulated by concurrently produced prostaglandin E2.
Yamada M; Watanabe M; Mue S; Ohuchi K
J Pharmacol Exp Ther; 1996 Jun; 277(3):1607-14. PubMed ID: 8667229
[TBL] [Abstract][Full Text] [Related]
22. Prostaglandin E2 receptor heterogeneity and dysfunction in mammary tumor cells.
Fulton AM; Laterra JJ; Hanchin CM
J Cell Physiol; 1989 Apr; 139(1):93-9. PubMed ID: 2540214
[TBL] [Abstract][Full Text] [Related]
23. Protein phosphatase-2A associates with the cytoskeleton to maintain cell spreading and reduced motility of nonmetastatic Lewis lung carcinoma cells: the loss of this regulatory control in metastatic cells.
Jackson J; Meisinger J; Patel S; Lim ZC; Vellody K; Metz R; Young MR
Invasion Metastasis; 1997; 17(4):199-209. PubMed ID: 9778592
[TBL] [Abstract][Full Text] [Related]
24. Prostaglandin E2 induces vascular endothelial growth factor and basic fibroblast growth factor mRNA expression in cultured rat Müller cells.
Cheng T; Cao W; Wen R; Steinberg RH; LaVail MM
Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):581-91. PubMed ID: 9501870
[TBL] [Abstract][Full Text] [Related]
25. Induction of cAMP-dependent protein kinase (PKA) activity in T cells after stimulation of the prostaglandin E2 or the beta-adrenergic receptors: relationship between PKA activity and inhibition of anti-CD3 monoclonal antibody-induced T cell proliferation.
Bauman GP; Bartik MM; Brooks WH; Roszman TL
Cell Immunol; 1994 Oct; 158(1):182-94. PubMed ID: 8087864
[TBL] [Abstract][Full Text] [Related]
26. Costimulatory signals modulate the antiproliferative effects of agents that elevate cAMP in T cells.
Bartik MM; Bauman GP; Brooks WH; Roszman TL
Cell Immunol; 1994 Oct; 158(1):116-30. PubMed ID: 8087859
[TBL] [Abstract][Full Text] [Related]
27. Prostaglandin E2 stimulates DNA synthesis by a cyclic AMP-independent pathway in osteoblastic clone MC3T3-E1 cells.
Hakeda Y; Yoshino T; Natakani Y; Kurihara N; Maeda N; Kumegawa M
J Cell Physiol; 1986 Aug; 128(2):155-61. PubMed ID: 2426284
[TBL] [Abstract][Full Text] [Related]
28. PGE2 induces IL-1beta gene expression in mouse osteoblasts through a cAMP-PKA signaling pathway.
Park YG; Kang SK; Noh SH; Park KK; Chang YC; Lee YC; Kim CH
Int Immunopharmacol; 2004 Jun; 4(6):779-89. PubMed ID: 15135319
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of the transendothelial migration of human T lymphocytes by prostaglandin E2.
Oppenheimer-Marks N; Kavanaugh AF; Lipsky PE
J Immunol; 1994 Jun; 152(12):5703-13. PubMed ID: 8207201
[TBL] [Abstract][Full Text] [Related]
30. Protein phosphatases limit tumor motility.
Young MR; Lozano Y; Djorjevic A; Maier GD
Int J Cancer; 1993 Jul; 54(6):1036-41. PubMed ID: 8392979
[TBL] [Abstract][Full Text] [Related]
31. Prostaglandin-E2-induced activation of adenosine 3'-5' cyclic monophosphate-dependent protein kinases of a murine macrophage-like cell line (P388D1).
Yamamoto H; Suzuki T
J Immunol; 1987 Nov; 139(10):3416-21. PubMed ID: 2824605
[TBL] [Abstract][Full Text] [Related]
32. Lipoteichoic acid-induced nitric oxide synthase expression in RAW 264.7 macrophages is mediated by cyclooxygenase-2, prostaglandin E2, protein kinase A, p38 MAPK, and nuclear factor-kappaB pathways.
Chang YC; Li PC; Chen BC; Chang MS; Wang JL; Chiu WT; Lin CH
Cell Signal; 2006 Aug; 18(8):1235-43. PubMed ID: 16289764
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of spleen cell cytotoxic capacity toward tumor by elevated prostaglandin E2 levels in mice bearing Lewis lung carcinoma.
Young MR; Hoover CS
J Natl Cancer Inst; 1986 Aug; 77(2):425-9. PubMed ID: 2942724
[TBL] [Abstract][Full Text] [Related]
34. Changes in VEGF level and tumor growth characteristics during lewis lung carcinoma progression towards cis-DDP resistance.
Pyaskovskaya ON; Dasyukevich OI; Kolesnik DL; Garmanchouk LV; Todor IN; Solyanik GI
Exp Oncol; 2007 Sep; 29(3):197-202. PubMed ID: 18004244
[TBL] [Abstract][Full Text] [Related]
35. Prostaglandin E2 stimulates IL-8 gene expression in human colonic epithelial cells by a posttranscriptional mechanism.
Yu Y; Chadee K
J Immunol; 1998 Oct; 161(7):3746-52. PubMed ID: 9759900
[TBL] [Abstract][Full Text] [Related]
36. Prostaglandin E2 induces vascular endothelial growth factor secretion in prostate cancer cells through EP2 receptor-mediated cAMP pathway.
Wang X; Klein RD
Mol Carcinog; 2007 Nov; 46(11):912-23. PubMed ID: 17427962
[TBL] [Abstract][Full Text] [Related]
37. Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner.
Krysan K; Reckamp KL; Dalwadi H; Sharma S; Rozengurt E; Dohadwala M; Dubinett SM
Cancer Res; 2005 Jul; 65(14):6275-81. PubMed ID: 16024629
[TBL] [Abstract][Full Text] [Related]
38. Growth and protein phosphorylation in the Nb2 lymphoma: effect of prolactin, cAMP, and agents that activate adenylate cyclase.
Rayhel EJ; Hughes JP; Svihla DA; Prentice DA
J Cell Biochem; 1990 Aug; 43(4):327-37. PubMed ID: 2168897
[TBL] [Abstract][Full Text] [Related]
39. Autocrine regulation of corneal endothelium by prostaglandin E2.
Jumblatt MM
Invest Ophthalmol Vis Sci; 1994 May; 35(6):2783-90. PubMed ID: 8188473
[TBL] [Abstract][Full Text] [Related]
40. Nucleotide-binding domain of phosphoglycerate kinase 1 reduces tumor growth by suppressing COX-2 expression.
Ho MY; Tang SJ; Ng WV; Yang W; Leu SJ; Lin YC; Feng CK; Sung JS; Sun KH
Cancer Sci; 2010 Nov; 101(11):2411-6. PubMed ID: 20731664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
